INS and metabolic dysfunction-associated steatotic liver disease: Several observational studies have suggested that liver fat accumulation or NAFLD negatively impacts triglyceride-rich lipoprotein metabolism, glucose–insulin homeostasis as well as branched-chain amino acid levels [12,13,14,15,16].